Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eunice Wang

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
Reversible cardiotoxicity with tyrosine kinase inhibitorsJawad Francis, Manmeet S Ahluwalia, Meir Wetzler, et al.
Cancers|September 9, 2022
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic ChallengesHassan Awada, Moaath K Mustafa Ali, Bicky Thapa, et al.
Cancers|November 13, 2021
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436Fatih M Uckun, Justin Watts, Alice S Mims, et al.
Frontiers in Oncology|January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMAJustin Watts, Tara L Lin, Alice Mims, et al.
The Journal of Biological Chemistry|August 7, 2009
Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivoAngela Chamberland, Eunice Wang, Aled R Jones, et al.
Arthritis and Rheumatism|August 31, 2004
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout miceSonya S Glasson, Roger Askew, Barbara Sheppard, et al.
Leukemia & Lymphoma|November 13, 2025
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patientsTheresa Hahn, Megan M Herr, Paul K Wallace, et al.
Leukemia Research|May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancyChetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.
International Journal of Molecular Sciences|October 26, 2024
Immune Checkpoint Inhibitor Therapy and Associations with Clonal HematopoiesisAbhay Singh, Nuria Mencia Trinchant, Rahul Mishra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Acute myeloid leukemiaMargaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Advances in Hematology & Oncology : H&O|April 14, 2010
Reversible cardiotoxicity with tyrosine kinase inhibitorsJawad Francis, Manmeet S Ahluwalia, Meir Wetzler, et al.
Cancers|September 9, 2022
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic ChallengesHassan Awada, Moaath K Mustafa Ali, Bicky Thapa, et al.
Cancers|November 13, 2021
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436Fatih M Uckun, Justin Watts, Alice S Mims, et al.
Frontiers in Oncology|January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMAJustin Watts, Tara L Lin, Alice Mims, et al.
The Journal of Biological Chemistry|August 7, 2009
Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivoAngela Chamberland, Eunice Wang, Aled R Jones, et al.
Arthritis and Rheumatism|August 31, 2004
Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout miceSonya S Glasson, Roger Askew, Barbara Sheppard, et al.
Leukemia & Lymphoma|November 13, 2025
Analysis of epidemiologic factors and treatment effects on immunophenotypes in hematologic malignancy patientsTheresa Hahn, Megan M Herr, Paul K Wallace, et al.
Leukemia Research|May 15, 2020
Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancyChetasi Talati, Aaron D Goldberg, Amanda Przespolewski, et al.
International Journal of Molecular Sciences|October 26, 2024
Immune Checkpoint Inhibitor Therapy and Associations with Clonal HematopoiesisAbhay Singh, Nuria Mencia Trinchant, Rahul Mishra, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 30, 2009
Acute myeloid leukemiaMargaret R O'Donnell, Frederick R Appelbaum, Steven E Coutre, et al.
Pageof 3